Connect with us

Hi, what are you looking for?


Vaccinated pregnant women pass protection to babies in study

Pregnant women who get mRNA vaccines pass high levels of antibodies to their babies, according to a study published in American Journal of Obstetrics & Gynecology – Maternal Fetal Medicine on Wednesday.

The study — one of the first to measure antibody levels in umbilical cord blood to distinguish whether immunity is from infection or vaccines — found that 36 newborns tested at birth all had antibodies to protect against COVID-19 after their mothers were vaccinated with shots from Pfizer Inc.-BioNTech SE or Moderna Inc.

“We didn’t anticipate that. We expected to see more variability,” said Ashley Roman, an obstetrician at NYU Langone Health System and co-author of the study.

The data could help encourage more women to get vaccinated during their pregnancies. Only 30% of pregnant women ages 18 to 49 are vaccinated, according to Centers for Disease Control and Prevention data from Sept. 11, despite growing evidence of prenatal vaccine safety. Given the study’s small sample size, the team is now looking at results from a larger group, as well as how long immunization lasts for infants after birth.

“We pushed this data out relatively early because it’s a unique finding and it has important implications for care,” Roman said. “Right now we’re recommending all pregnant women receive the vaccine for maternal benefit.”

The National Institutes of Health began a study called MOMI-VAX to measure how long antibodies against Covid-19 will last in people vaccinated during pregnancy. The same researchers will also assess the transfer of vaccine-induced antibodies to infants across the placenta and breast milk.

The CDC’s vaccine advisory panel met Wednesday for a general review of vaccine efficacy and safety. They’ve gathered more data on vaccines’ safety during pregnancy from v-safe, a CDC-established registry for people who say they’re pregnant at the time of vaccination, according to Christine Olson, a doctor on the so-called ACIP committee. According to the registry, there’s no evidence vaccines harm the fetus.

Pfizer and BioNTech are also studying how their shots affect pregnant women and their babies. The drugmakers “stopped enrollment in the U.S. because of recommendations encouraging vaccination of pregnant women,” Pfizer said in an emailed statement to Bloomberg after the Wall Street Journal reported the delay Wednesday, citing concerns that women in the study might get a placebo. The companies are looking at sites in countries that don’t advise pregnant women to get shots for possible study sites, according to the statement.

The researchers studied cord blood of 36 fully vaccinated women to look for antibodies to spike protein, which appears after vaccination or getting sick from COVID, and to nucleocapsid protein, which is only present after getting COVID. Prior studies focused on antibodies to the spike protein.

Among the 36 samples the researchers looked at, 31 tested negative for antibodies to the nucleocapsid protein. In other words, 31 pregnant women developed immunity from the vaccine. The other five weren’t tested for nucleocapsid protein, so the researchers can’t conclusively say the immunity was from the vaccine or from natural infection.

The findings show “very encouraging levels of antibody in cord blood,” said Linda Eckert, an obstetrics and gynecology professor at the University of Washington who wasn’t involved in the study. “This is another reason pregnant women should get vaccinated, as we are seeing more disease in younger infants and this is a proactive choice pregnant individuals can make to protect their infants.” — Bloomberg

Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!



GLENN CARSTENS PETERS-UNSPLASH For companies to digitally transform, people will need to be upskilled and reskilled to embrace new tools with the goal of...


A woman walks across the city centre bridge in Melbourne, Australia, July 16, 2021. — REUTERS/SANDRA SANDERS SYDNEY — Millions in Melbourne are readying...


METROCOM relaxing while waiting to be deployed near Malacanang on Sept. 21, 1983. — AITOR ALEGRIA Many of us still remember the box office...


STARLINE Because it is the rainy season, the weather is among the many concerns that worry many Filipinos, and the damage and casualties from...


CHINA has seen rapid urbanization; as of 2020, 61% of its population lived in urban areas. In 1960, that number was a mere 16%....


FREEPIK The concept of “choosing the lesser evil” seems to say that when a person is faced with two undesirable (i.e., two unfortunate or...

You May Also Like

When people envision technology overtaking society, many think of The Terminator and bulletproof robots. Or Big Brother in George Orwell’s Nineteen Eighty-Four, a symbol...

Financial Advisors

Stock Markets9 hours ago (Jul 02, 2020 04:45AM ET) (C) Reuters. ROME (Reuters) – World food prices rose in June to post their first...


SAN FRANCISCO — The spread of the coronavirus has meant feast or famine for technology start-ups. While many are cutting staff and slashing costs...


OAKLAND, Calif. — Jack Dorsey has won plaudits for his corporate activism during the coronavirus crisis, taking on President Trump in his role as...

Disclaimer: Respect, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 Respect Investment. All Rights Reserved.

Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!